Comparison of Switching to Direct Oral Anticoagulants and Continuous Low-Molecular-Weight Heparin in the Treatment of Cancer-Associated Venous Thromboembolism in Taiwan

被引：0
|
作者：
Kang, Wei [1 ]
Shen, Chin-Yao [2 ]
Cheng, Michael Chun-Yuan [3 ]
Yan, Vincent Kc [4 ]
Wei, Yue [5 ]
Li, Tung Hiu [6 ]
Huang, Caige [5 ]
Lai, Edward Chia-Cheng [7 ]
Wong, Ian Chi Kei [4 ]
Chan, Esther W. [4 ]
机构：
[1] Univ Hong Kong, Hong Kong, Peoples R China
[2] Natl Cheng Kung Univ, Inst Clin Pharm & Pharmaceut Sci, Sch Pharm, Coll Med, Tainan, Taiwan
[3] Natl Cheng Kung Univ, Inst Clin Pharm & Pharmaceut Sci, Coll Med, Tainan, Taiwan
[4] Univ Hong Kong, Li Ka Shing Fac Med, Dept Pharmacol & Pharm, Ctr Safe Medicat Practice & Res, Hong Kong, Peoples R China
[5] Univ Hong Kong, Dept Pharmacol & Pharm, Ctr Safe Medicat Practice & Res, Hong Kong, Peoples R China
[6] Univ Hong Kong, Li Ka Shing Fac Med, Dept Pharmacol & Pharm, Hong Kong, Peoples R China
[7] Natl Cheng Kung Univ, Inst Clin Pharm & Pharmaceut Sci, Coll Med, Tainan, Taiwan
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2024年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
220
引用
收藏
页码：77 / 77
页数：1
相关论文
共 50 条
  • [21] LOW-MOLECULAR-WEIGHT HEPARIN TREATMENT OF VENOUS THROMBOEMBOLISM
    HULL, RD
    PINEO, GF
    PROGRESS IN CARDIOVASCULAR DISEASES, 1994, 37 (02) : 71 - 78
  • [22] Treatment of venous thromboembolism with low-molecular-weight heparin
    Hull, RD
    Pineo, GF
    INTERNATIONAL CONGRESS OF PHLEBOLOGY, 1996, : 269 - 281
  • [23] Low-molecular-weight heparin in the treatment of venous thromboembolism
    Hull, RD
    Pineo, GF
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2000, 26 : 61 - 67
  • [24] Low-molecular-weight heparin for the treatment of venous thromboembolism
    Hull, RD
    Pineo, GF
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 1996, 17 (01) : 65 - 70
  • [25] The Role of Direct Oral Anticoagulants in Cancer-Associated Venous Thromboembolism
    Hueftle, Brooke
    Kator, Sarah
    JNP-JOURNAL FOR NURSE PRACTITIONERS, 2019, 15 (07): : 528 - 529
  • [26] Edoxaban is non-inferior to low-molecular-weight heparin for treating cancer-associated venous thromboembolism
    Linkins, Lori-Ann
    BMJ EVIDENCE-BASED MEDICINE, 2018, 23 (06) : 230 - 230
  • [27] Comparison between direct factor Xa inhibitors and low-molecular-weight heparin for efficacy and safety in the treatment of cancer-associated venous thromboembolism: A meta-analysis
    Yang, Min
    Li, Jiang
    Sun, Rui
    Wang, Yanfeng
    Xu, Haiyan
    Yang, Boyan
    Wu, Xiaoming
    Yu, Lei
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2019, 15 (07) : 1541 - 1546
  • [28] Meta-Analysis Comparing Direct Oral Anticoagulants to Low Molecular Weight Heparin for Treatment of Venous Thromboembolism in Patients With Cancer
    Bhatia, Kirtipal
    Uberoi, Guneesh
    Bajaj, Navkaranbir S.
    Jain, Vardhmaan
    Arora, Sameer
    Tafur, Alfonso
    Bangalore, Sripal
    Olin, Jeffrey W.
    Piazza, Gregory
    Goldhaber, Samuel Z.
    Vaduganathan, Muthiah
    Qamar, Arman
    AMERICAN JOURNAL OF CARDIOLOGY, 2020, 133 : 175 - 178
  • [29] Direct oral anticoagulants or low-molecular-weight heparins for venous thromboembolism in patients with brain tumors
    Lee, Angela
    Oley, Frank, Jr.
    Lo, Mimi
    Fong, Richard
    McGann, Mary
    Saunders, Ila
    Block, Shanna
    Mahajan, Anjlee
    Pon, Tiffany K.
    THROMBOSIS RESEARCH, 2021, 208 : 148 - 155
  • [30] Low-molecular-weight heparin for initial treatment of venous thromboembolism
    Brewer, D
    AMERICAN FAMILY PHYSICIAN, 2005, 72 (01) : 75 - 76
12345